GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Recruiting · NCT04864054 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT04864054 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eureka Therapeutics Inc. | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Fred Hutchinson Cancer Center, University of Washington | Seattle | United States | 1 |
| Kansas University Medical Center, Principal Investigator: | Westwood | United States | 1 |
| Montefiore Einstein Comprehensive Cancer Center | The Bronx | United States | 5 |
| National Taiwan University Cancer Center | Taipei | Taiwan | 12 |
| Oregon Health and Sciences University | Portland | United States | 20 |
| Roswell Park Comprehensive Cancer Center | Buffalo | United States | 63 |
| University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center | Dallas | United States | 1 |